基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 4,733.68
成立日期: 26/01/2004
 
分析
市值分佈:
95.66%
大市值
2.86%
中市值
0.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:00) 總持有投資項目: 405  
0%
 
100%
     10大 (50.46%)
代號 名稱 佔比% 持有日期
ARDTArdent Health Inc0.00431/03/2026
EDITEditas Medicine0.00431/03/2026
TRDAEntrada Therapeutics0.00431/03/2026
SIGASIGA Technologies0.00431/03/2026
LABStandard BioTools0.00431/03/2026
VSTMVerastem0.00431/03/2026
RZLTRezolute0.00431/03/2026
UPBUpstream Bio Inc0.00431/03/2026
EVHEvolent Health0.00331/03/2026
RXSTRxSight0.00331/03/2026
DNAGinkgo Bioworks Holdings0.00331/03/2026
ARCTArcturus Therapeutics Holdings0.00331/03/2026
SLPSimulations Plus0.00331/03/2026
EOLSEvolus0.00331/03/2026
OSUROraSure Technologies0.00331/03/2026
OMI--0.00330/11/2025
KROSKeros Therapeutics0.00331/03/2026
GDRXGoodRx Holdings0.00331/03/2026
ALECAlector0.00331/03/2026
LYELLyell Immunopharma Inc0.00231/03/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18   19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.